Osteomalacia induced by adefovir in patient with hepatitis B
Reumatol Clin. 2014 Mar-Apr;10(2):120-1.
doi: 10.1016/j.reuma.2013.01.006.
Epub 2013 May 8.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Reumatología, Hospital Cruces, Barakaldo, Vizcaya, España. Electronic address: nathali_r17@hotmail.com.
- 2 Servicio de Reumatología, Hospital Cruces, Barakaldo, Vizcaya, España.
Abstract
Osteomalacia is defined as a defect in mineralization of the bone matrix. We describe the case of a patient with chronic hepatitis B infection in whom treatment with adefovir induced renal phosphate loss with intense and sustained hypophosphatemia which derived in symptomatic osteomalacia.
Keywords:
Adefovir; Hipofosfatemia; Hypophosphatemia; Osteomalacia.
Copyright © 2012 Elsevier España, S.L. All rights reserved.
MeSH terms
-
Adenine / adverse effects
-
Adenine / analogs & derivatives*
-
Adenine / therapeutic use
-
Aged, 80 and over
-
Antiviral Agents / adverse effects*
-
Antiviral Agents / therapeutic use
-
Hepatitis B, Chronic / complications
-
Hepatitis B, Chronic / drug therapy*
-
Humans
-
Male
-
Organophosphonates / adverse effects*
-
Organophosphonates / therapeutic use
-
Osteomalacia / chemically induced*
-
Osteomalacia / diagnosis
Substances
-
Antiviral Agents
-
Organophosphonates
-
adefovir
-
Adenine